Found 8 matching trials
BTZ-043 Dose Evaluation in Combination and Selection PHASE2 This is a phase 2B, open label study, that will compare the safety and effi...
Show More Location
TASK Applied Sciences Clinical Research Centre
Learn More & Join Trial
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB PHASE2 The UNITE4TB consortium is a group of universities and pharmaceutical compa...
Show More Location
PMSI Institute of Pneumology "Chiril Draganiuc"
Learn More & Join Trial
Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis PHASE2 A phase 2, two-part, multicentre, open label, controlled, randomised clinic...
Show More Learn More & Join Trial
Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis PHASE2 This study measured the early bactericidal activity (EBA), safety, tolerabi...
Show More Location
GSK Investigational Site
Learn More & Join Trial
PanACEA - STEP2C -01 PHASE2 This is a phase 2B/C, open label platform study that will compare the effic...
Show More Location
Centre de Recherches Médicales de Lambaréné (CERMEL)
Learn More & Join Trial
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) PHASE1 This is a prospective, open label, two-centre, randomized, controlled, two-...
Show More Location
TASK Applied Sciences Clinical Research Centre
Learn More & Join Trial
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment PHASE1 This study is a Phase 1, single-center, open-label study to investigate the...
Show More Location
PRA Health Sciences (PRA) - Early Development Services (EDS)
Learn More & Join Trial
A Single Ascending Dose Study of BTZ043 PHASE1 This study is a randomized, double-blind, placebo-controlled, single ascend...
Show More Learn More & Join Trial